Back to search

Article

FAM111B, LAG3, and FGL1, A Three-Gene Signature as a Predictive Biomarker for Immunotherapy Response in Bladder Urothelial Carcinoma

2026-08-18

Abstract excerpt

<title>Abstract</title> <p>Background Immunotherapy has markedly extended survival in some patients with bladder urothelial carcinoma (BLCA). However, only a subset of patients experience sustained clinical benefit. Thus, the identification of reliable biomarkers for predicting immunotherapy response are required. Methods Transcriptomic and clinical data from the IMvigor210 cohort treated with anti–PD-L1 therap...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
bcbcaef5-cad7-52c4-bad3-e1699656330d
DOI
10.21203/rs.3.rs-9483128/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
FAM111B, LAG3, and FGL1, A Three-Gene Signature as a Predictive Biomarker for Immunotherapy Response in Bladder Urothelial CarcinomaDOI 10.21203/rs.3.rs-9483128/v1
Select a neighboring publication to make it the new centre.